Veterinary Medicines

DACLOTRIX 200 mg/40 mg spot-on solution for dogs up to 4 kg

Authorised
  • Permethrin (40:60)
  • Imidacloprid
Download as PDF

Product identification

Medicine name:
DACLOTRIX 200 mg/40 mg spot-on solution for dogs up to 4 kg
DACLOTRIX 200 mg/40 mg spot-on solution for dogs up to 4 kg
Active substance:
  • Permethrin (40:60)
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Permethrin (40:60)
    200.00
    milligram(s)
    /
    1.00
    Pipette
  • Imidacloprid
    40.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Spot-on use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 1 ml pipette containing 0.4 ml of solution Box containing 10 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 1 ml pipette containing 0.4 ml of solution Box containing 6 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 1 ml pipette containing 0.4 ml of solution Box containing 4 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 1 ml pipette containing 0.4 ml of solution Box containing 3 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 1 ml pipette containing 0.4 ml of solution Box containing 1 pipette

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Krka d.d. Novo Mesto
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10774/074/001
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0774/001
Concerned member states:
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
Average: 5 (5 votes)
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."